Oncology Today with Dr Neil Love cover image

Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation

Oncology Today with Dr Neil Love

00:00

Is There a Higher Risk of TKI's After Immunotherapy?

The rate of hypothyroidism is highly correlated with the duration that patients spend on study. So I think it's important to remember that some of these toxicities can be delayed and that thyroid, in fact, if you look, someone who progresses on their initial therapy, would probably start after they've stopped immunotherapy. The one that so far things have been a little bit better on has been some of the B-ref inhibitors.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app